| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.75B | +16.6% |
| Cost of Revenue | $421.4M | +7.9% |
| Gross Profit | $1.32B | +19.7% |
| R&D Expense | $312.7M | +4.9% |
| SG&A Expense | $148.7M | +31.8% |
| Operating Income | $263.1M | +112.4% |
| Pre-tax Income | $280.6M | +96.7% |
| Income Tax | -$112.8M | -359.6% |
| Net Income | $393.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $212.4M | -37.0% |
| Short-term Investments | $213.4M | -47.0% |
| Accounts Receivable | $264.7M | -13.3% |
| Current Assets | $978.3M | -26.6% |
| Total Assets | $1.63B | -7.7% |
| Current Liabilities | $737.8M | -32.1% |
| Total Liabilities | $844.5M | -28.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $505.2M | +46.1% |
| Capital Expenditures | $14.5M | +88.1% |
| Investing Cash Flow | $197.2M | +197.4% |
| Financing Cash Flow | -$834.6M | -2662.4% |
| Free Cash Flow | $490.7M | +45.1% |
| +296.7% |
| EPS (Basic) | $2.30 | +98.3% |
| EPS (Diluted) | $2.13 | +91.9% |
| Stockholders' Equity |
| $787.4M |
| +34.5% |